|
1
|
Hansson GK, Libby P and Tabas I:
Inflammation and plaque vulnerability. J Intern Med. 278:483–493.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Falk E, Nakano M, Bentzon JF, Finn AV and
Virmani R: Update on acute coronary syndromes: The pathologists'
view. Eur Heart J. 34:719–728. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haasdijk RA, Den Dekker WK, Cheng C,
Tempel D, Szulcek R, Bos FL, Hermkens DM, Chrifi I, Brandt MM, Van
Dijk C, et al: THSD1 preserves vascular integrity and protects
against intraplaque haemorrhaging in ApoE−/− mice.
Cardiovasc Res. 110:129–139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kolodgie FD, Gold HK, Burke AP, Fowler DR,
Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, et al:
Intraplaque hemorrhage and progression of coronary atheroma. N Engl
J Med. 349:2316–2325. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Moreno PR, Purushothaman KR, Zias E, Sanz
J and Fuster V: Neovascularization in human atherosclerosis. Curr
Mol Med. 6:457–477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Taruya A, Tanaka A, Nishiguchi T, Matsuo
Y, Ozaki Y, Kashiwagi M, Shiono Y, Orii M, Yamano T, Ino Y, et al:
Vasa Vasorum Restructuring in Human Atherosclerotic Plaque
Vulnerability: A clinical optical coherence tomography study. J Am
Coll Cardiol. 65:2469–2477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chang SH, Feng D, Nagy JA, Sciuto TE,
Dvorak AM and Dvorak HF: Vascular permeability and pathological
angiogenesis in caveolin-1-null mice. Am J Pathol. 175:1768–1776.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Michel JB, Martin-Ventura JL, Nicoletti A
and Ho-Tin-Noe B: Pathology of human plaque vulnerability:
Mechanisms and consequences of intraplaque haemorrhages.
Atherosclerosis. 234:311–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brogi E, Wu T, Namiki A and Isner JM:
Indirect angiogenic cytokines upregulate VEGF and bFGF gene
expression in vascular smooth muscle cells, whereas hypoxia
upregulates VEGF expression only. Circulation. 90:649–652. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ahmad S, Hewett PW, Wang P, Al-Ani B,
Cudmore M, Fujisawa T, Haigh JJ, le Noble F, Wang L, Mukhopadhyay D
and Ahmed A: Direct evidence for endothelial vascular endothelial
growth factor receptor-1 function in nitric oxide-mediated
angiogenesis. Circ Res. 99:715–722. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Belgore F, Blann A, Neil D, Ahmed AS and
Lip GY: Localisation of members of the vascular endothelial growth
factor (VEGF) family and their receptors in human atherosclerotic
arteries. J Clin Pathol. 57:266–272. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Perrot-Applanat M and Di Benedetto M:
Autocrine functions of VEGF in breast tumor cells: Adhesion,
survival, migration and invasion. Cell Adh Migr. 6:547–553. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Choi HS, Kim MK, Lee K, Lee KM, Choi YK,
Shin YC, Cho SG and Ko SG: SH003 represses tumor angiogenesis by
blocking VEGF binding to VEGFR2. Oncotarget. 7:32967–32979.
2016.
|
|
14
|
Mancini M, Greco A, Salvatore G, Liuzzi R,
Di Maro G, Vergara E, Chiappetta G, Pasquinelli R, Brunetti A and
Salvatore M: Imaging of thyroid tumor angiogenesis with
microbubbles targeted to vascular endothelial growth factor
receptor type 2 in mice. BMC Med Imaging. 13:312013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tekabe Y, Kollaros M, Zerihoun A, Zhang G,
Backer MV, Backer JM and Johnson LL: Imaging VEGF receptor
expression to identify accelerated atherosclerosis. EJNMMI Res.
4:412014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang K, Pan D, Schmieder AH, Senpan A,
Caruthers SD, Cui G, Allen JS, Zhang H, Shen B and Lanza GM:
Atherosclerotic neovasculature MR imaging with mixed
manganese-gadolinium nanocolloids in hyperlipidemic rabbits.
Nanomedicine. 11:569–578. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schinkel AF, van den Oord SC, Van Der
Steen AF, van Laar JA and Sijbrands EJ: Utility of
contrast-enhanced ultrasound for the assessment of the carotid
artery wall in patients with Takayasu or giant cell arteritis. Eur
Heart J Cardiovasc Imaging. 15:541–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Romero JM, Pizzolato R, Atkinson W, Meader
A, Jaimes C, Lamuraglia G, Jaff MR, Buonanno F, Almandoz J Delgado
and Gonzalez RG: Vasa vasorum enhancement on computerized
tomographic angiography correlates with symptomatic patients with
50 to 70% carotid artery stenosis. Stroke. 44:3344–3349. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hrkach J, Von Hoff D, Ali M Mukkaram,
Andrianova E, Auer J, Campbell T, De Witt D, Figa M, Figueiredo M,
Horhota A, et al: Preclinical development and clinical translation
of a PSMA-targeted docetaxel nanoparticle with a differentiated
pharmacological profile. Sci Transl Med. 4:128ra392012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pisani E, Tsapis N, Galaz B, Santin M,
Berti R, Taulier N, Kurtisovski E, Lucidarme O, Ourevitch M, Doan
BT, et al: Perfluorooctyl Bromide Polymeric Capsules as Dual
Contrast Agents for Ultrasonography and Magnetic Resonance Imaging.
Adv Funct Mater. 18:2963–2971. 2008. View Article : Google Scholar
|
|
21
|
Ghosh D, Lee Y, Thomas S, Kohli AG, Yun
DS, Belcher AM and Kelly KA: M13-templated magnetic nanoparticles
for targeted in vivo imaging of prostate cancer. Nat Nanotechnol.
7:677–682. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li S, Ma Y, Yue X, Cao Z and Dai Z:
One-pot construction of doxorubicin conjugated magnetic silica
nanoparticles. New J Chem. 33:2414–2418. 2009. View Article : Google Scholar
|
|
23
|
Liu J, Li J, Rosol TJ, Pan X and Voorhees
JL: Biodegradable nanoparticles for targeted ultrasound imaging of
breast cancer cells in vitro. Phys Med Biol. 52:4739–4747. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hermanson GT: Bioconjugate Techniques. I.
Academic Press; London: pp. 169–172. 1996, View Article : Google Scholar
|
|
25
|
Tian C, Zhang R, Ye X, Zhang C, Jin X,
Yamori Y, Hao L, Sun X and Ying C: Resveratrol ameliorates
high-glucose-induced hyperpermeability mediated by caveolae via
VEGF/KDR pathway. Genes Nutr. 8:231–239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fonseca FA, Paiva TB, Silva EG, Ihara SS,
Kasinski N, Martinez TL and Filho EE: Dietary magnesium improves
endothelial dependent relaxation of balloon injured arteries in
rats. Atherosclerosis. 139:237–242. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan F, Yang W, Li X, Liu H, Nan X, Xie L,
Zhou D, Xie G, Wu J, Qiu B, et al: Magnetic resonance imaging of
atherosclerosis using CD81-targeted microparticles of iron oxide in
mice. Biomed Res Int. 2015:7586162015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guo S, Shen S, Wang J, Wang H, Li M, Liu
Y, Hou F, Liao Y and Bin J: Detection of high-risk atherosclerotic
plaques with ultrasound molecular imaging of glycoprotein IIb/IIIa
receptor on activated platelets. Theranostics. 5:418–430. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reimer P and Balzer T: Ferucarbotran
(Resovist): A new clinically approved RES-specific contrast agent
for contrast-enhanced MRI of the liver: Properties, clinical
development, and applications. Eur Radiol. 13:1266–1276.
2003.PubMed/NCBI
|
|
30
|
Wiesner P, Tafelmeier M, Chittka D, Choi
SH, Zhang L, Byun YS, Almazan F, Yang X, Iqbal N, Chowdhury P, et
al: MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in
human plasma. J Lipid Res. 54:1877–1883. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hsu WY, Chao YW, Tsai YL, Lien CC, Chang
CF, Deng MC, Ho LT, Kwok CF and Juan CC: Resistin induces
monocyte-endothelial cell adhesion by increasing ICAM-1 and VCAM-1
expression in endothelial cells via p38MAPK-dependent pathway. J
Cell Physiol. 226:2181–2188. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fotis L, Agrogiannis G, Vlachos IS,
Pantopoulou A, Margoni A, Kostaki M, Verikokos C, Tzivras D,
Mikhailidis DP and Perrea D: Intercellular adhesion molecule
(ICAM)-1 and vascular cell adhesion molecule (VCAM)-1 at the early
stages of atherosclerosis in a rat model. In Vivo. 26:243–250.
2012.PubMed/NCBI
|
|
33
|
Deyama J, Nakamura T, Takishima I, Fujioka
D, Kawabata K, Obata JE, Watanabe K, Watanabe Y, Saito Y, Mishina H
and Kugiyama K: Contrast-enhanced ultrasound imaging of carotid
plaque neovascularization is useful for identifying high-risk
patients with coronary artery disease. Circ J. 77:1499–1507. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li X, Bauer W, Israel I, Kreissl MC,
Weirather J, Richter D, Bauer E, Herold V, Jakob P, Buck A, et al:
Targeting P-selectin by gallium-68-labeled fucoidan positron
emission tomography for noninvasive characterization of vulnerable
plaques: Correlation with in vivo 17.6T MRI. Arterioscler Thromb
Vasc Biol. 34:1661–1667. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Daeichin V, Kooiman K, Skachkov I, Bosch
JG, Theelen TL, Steiger K, Needles A, Janssen BJ, Daemen MJ, Van
Der Steen AF, et al: Quantification of Endothelial αvβ3 expression
with high-frequency ultrasound and targeted Microbubbles: In vitro
and In vivo Studies. Ultrasound Med Biol. 42:2283–2293. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qi CM, Du L, Wu WH, Li DY, Hao J, Gong L,
Deng L, Zhang T, Zhang C and Zhang Y: Detection of Vulnerable
Atherosclerotic Plaques in Experimental Atherosclerosis with the
USPIO-Enhanced MRI. Cell Biochem Biophys. 73:331–337. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wang Y, Chen J, Yang B, Qiao H, Gao L, Su
T, Ma S, Zhang X, Li X, Liu G, et al: In vivo MR and Fluorescence
Dual-modality Imaging of Atherosclerosis Characteristics in Mice
Using Profilin-1 Targeted Magnetic Nanoparticles. Theranostics.
6:272–286. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
van Tilborg GA, Vucic E, Strijkers GJ,
Cormode DP, Mani V, Skajaa T, Reutelingsperger CP, Fayad ZA, Mulder
WJ and Nicolay K: Annexin A5-functionalized bimodal nanoparticles
for MRI and fluorescence imaging of atherosclerotic plaques.
Bioconjug Chem. 21:1794–1803. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gerber HP, McMurtrey A, Kowalski J, Yan M,
Keyt BA, Dixit V and Ferrara N: Vascular endothelial growth factor
regulates endothelial cell survival through the
phosphatidylinositol 3′-kinase/Akt signal transduction pathway.
Requirement for Flk-1/KDR activation. J Biol Chem. 273:30336–30343.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Arnott C, Punnia-Moorthy G, Tan J,
Sadeghipour S, Bursill C and Patel S: The Vascular Endothelial
Growth Factor Inhibitors Ranibizumab and Aflibercept Markedly
Increase Expression of Atherosclerosis-Associated Inflammatory
Mediators on Vascular Endothelial Cells. PLoS One. 11:e01506882016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kiessling F, Gaetjens J and Palmowski M:
Application of molecular ultrasound for imaging integrin
expression. Theranostics. 1:127–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Eckert MA, Vu PQ, Zhang K, Kang D, Ali MM,
Xu C and Zhao W: Novel molecular and nanosensors for in vivo
sensing. Theranostics. 3:583–594. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Díaz-López R, Tsapis N and Fattal E:
Liquid perfluorocarbons as contrast agents for ultrasonography and
(19)F-MRI. Pharm Res. 27:1–16. 2010. View Article : Google Scholar : PubMed/NCBI
|
